Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
Edit Result Fields| Symbol | APVO | ASNS | CRIS | ||
| Company | Aptevo Therapeutics Inc | Arsanis Inc | Curis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.67 | 2.60 | 1.13 | ||
| High | 1.73 | 2.71 | 1.16 | ||
| Low | 1.61 | 2.60 | 1.07 | ||
| Last | 1.67 | 2.69 | 1.13 | ||
| Change | +0.01 | +0.13 | +0.01 | ||
| % Change | +0.60% | +5.08% | +0.89% | ||
| Volume | 242,000 | 26,900 | 57,000 | ||
| 20-Day Average Volume | 132,880 | 65,235 | 230,985 | ||
| Previous Close | 1.66 | 2.56 | 1.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.65 | 2.77 | 1.14 | ||
| 20-Day Raw Stochastic | 48.44% | 56.14% | 30.43% | ||
| 20-Day Relative Strength | 46.56% | 47.09% | 52.65% | ||
| Weighted Alpha | -48.10 | -72.50 | -57.30 | ||
| Today's Opinion | 8% Sell | 24% Sell | 8% Sell | ||
| Previous Opinion | 16% Sell | 24% Sell | 8% Sell | ||
| Last Month's Opinion | 72% Sell | 64% Buy | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.60% since 02/14/19 | -2.54% since 02/14/19 | +8.65% since 02/14/19 | ||
| Low | 1.61 on 02/21/19 | 2.51 on 02/20/19 | 1.02 on 02/15/19 | ||
| High | 1.73 on 02/21/19 | 2.91 on 02/15/19 | 1.18 on 02/20/19 | ||
| 1-Month | |||||
| %Chg | +3.73% since 01/18/19 | -15.94% since 01/18/19 | -2.59% since 01/18/19 | ||
| Low | 1.36 on 01/30/19 | 2.05 on 02/13/19 | 0.99 on 02/14/19 | ||
| High | 2.00 on 02/05/19 | 3.35 on 01/22/19 | 1.45 on 01/24/19 | ||
| 3-Month | |||||
| %Chg | -36.26% since 11/21/18 | +126.05% since 11/21/18 | -11.72% since 11/21/18 | ||
| Low | 1.11 on 12/31/18 | 1.16 on 11/26/18 | 0.60 on 12/11/18 | ||
| High | 2.73 on 11/26/18 | 4.91 on 11/30/18 | 1.45 on 01/24/19 | ||
| 6-Month | |||||
| %Chg | -67.82% since 08/21/18 | +51.12% since 08/21/18 | -22.60% since 08/21/18 | ||
| Low | 1.11 on 12/31/18 | 1.15 on 11/14/18 | 0.60 on 12/11/18 | ||
| High | 5.73 on 09/04/18 | 4.91 on 11/30/18 | 2.37 on 10/16/18 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 38,093 | 38,494 | 37,414 | ||
| Shares Outstanding, K | 22,808 | 14,315 | 33,113 | ||
| Annual Sales, $M | 14,660,000 | 0 | 9,900,000 | ||
| Annual Net Income, $M | 6,970,000 | -33,880,000 | -53,320,000 | ||
| Last Quarter Sales, $M | 5,820,000 | N/A | 2,850,000 | ||
| Last Quarter Net Income, $M | -12,560,000 | N/A | -7,220,000 | ||
| 36-Month Beta | 3.08 | 1.86 | 2.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | 03/12/19 | 03/08/19 | 03/14/19 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||
